Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?

Frontiers in Public Health

article

David M. Livermore¹  Hildegund C. J. Ertl²  Sue L. Currie³ 

[1] Norwich Medical School, University of East Anglia;The Wistar Institute;Virion Therapeutics

关键词: COVID-19;    vaccinations;    adenovirus vector vaccine;    mRNA vaccine;    public health strategies;   

DOI  :  10.3389/fpubh.2022.929445

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

The SARS-CoV-2 pandemic started in March 2020, and, to date, has killed over 6 million people. Vaccines were developed with remarkable speed and reduced the death toll. Notwithstanding, the pandemic endures, and accumulating viral mutations are progressively reducing vaccine efficacy, which is short-lived, even against the original virus. Thus, the UK is recording 4.9 million infections per week, despite evidence that 99% of its 68 million population have anti-SARS-CoV-2 antibodies. Before we embark on endless booster immunizations, it is time to review our strategies against COVID-19.

【 授权许可】

CC BY